Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Rev Esp Anestesiol Reanim (Engl Ed) ; 69(2): 71-78, 2022 02.
Article in English | MEDLINE | ID: mdl-35183469

ABSTRACT

BACKGROUND: Celiac plexus neurolysis (CPN) has been used to control pancreatic cancer (PC) pain, up to our knowledge, there is no study compared intraoperative CPN and computed tomography (CT)-guided techniques. OBJECTIVES: To compare the effects of intraoperative and CT-guided CPN in unresectable PC on pain intensity and analgesic requirements. METHODS: A total of 90 patients were enrolled in this prospective, randomized, open label, controlled, non-inferiority study, 20 patients were excluded or lost to follow up. The patients were randomly allocated to either intraoperative or CT-guided CPN group. A mixture of 20 mL ethanol 90%, 100 mg lignocaine and 5 mg dexamethasone was infused on each side of the aorta in both groups. Visual analogue score (VAS) and oral daily tramadol consumption were recorded at day 7, 14, 30, 60, 120 and 180 days after intervention. Occurrence of any intervention related complications were reported. RESULTS: Median VAS was similar in both intraoperative and CT-guided CPN groups from day 7 up to 180 days after intervention. The median daily analgesic consumption of oral tramadol (mg) was comparable in both intraoperative and CT-guided CPN groups after intervention at day 7 (50 versus 50), day14 (50 versus 50), day 30 (50 versus 50), day 60 (50 versus 50), day 120 (100 versus 75) and day 180 (100 versus 100). The incidence of diarrhea, vomiting, hypotension and back pain was similar in both groups. CONCLUSION: Intraoperative CPN is non-inferior to CT-guided CPN as both techniques were similarly associated with reduced pain severity and analgesics requirements.


Subject(s)
Cancer Pain , Celiac Plexus , Pancreatic Neoplasms , Tramadol , Abdominal Pain/etiology , Analgesics , Celiac Plexus/surgery , Humans , Pancreatic Neoplasms/surgery , Prospective Studies , Tramadol/therapeutic use , Pancreatic Neoplasms
2.
Rev. esp. anestesiol. reanim ; 69(2): 71-78, Feb 2022. tab, ilus, graf
Article in Spanish | IBECS | ID: ibc-206705

ABSTRACT

Antecedentes: Se ha utilizado la neurólisis del plexo celiaco (NPC) para controlar el dolor producido por el cáncer de páncreas (CP) y, a nuestro entender, no existe ningún estudio que compare las técnicas de NPC intraoperatoria y NPC guiada por tomografía computarizada (TC). Objetivos: Comparar los efectos de NPC intraoperatoria y NPC guiada por TC en el CP no operable en cuanto a intensidad del dolor y necesidad de analgésicos. Métodos: Se incluyó a un total de 90 pacientes en este estudio prospectivo, aleatorizado, abierto, controlado y de no inferioridad, en el que se excluyó o perdió a 20 pacientes durante el seguimiento. Se asignó aleatoriamente a los pacientes en el grupo de NPC intraoperatoria o el grupo de NPC guiada por TC. En ambos grupos se inyectó una mezcla de 20ml de etanol al 90%, 100mg de lidocaína y 5mg de dexametasona en cada lado de la aorta. Se registraron la escala visual analógica (EVA) y el consumo oral diario de tramadol los días 7.°, 14.°, 30.°, 60.°, 120.° y 180.° tras la intervención. Se reportó la presencia de cualquier complicación relacionada con la intervención. Resultados: La puntuación EVA media fue similar en ambos grupos de NPC intraoperatoria y NPC guiada por TC desde el 7.° al 180.° posteriores la intervención. El consumo medio diario de analgésico (miligramos de tramadol por vía oral) fue comparable en ambos grupos tras la intervención en los días 7.°(50 frente a 50), 14.°(50 frente a 50), 3.0°(50 frente a 50), 60.°(50 frente a 50), 120.°(100 frente a 75) y 180.° (100 frente a 100). La incidencia de diarrea, vómitos, hipotensión y dolor de espalda fue similar en ambos grupos. Conclusión: La NPC intraoperatoria no es inferior a la NPC guiada por TC, ya que la asociación de ambas técnicas a la reducción de la gravedad del dolor y a las necesidades de analgésicos fue similar.(AU)


Background: Celiac plexus neurolysis (CPN) has been used to control pancreatic cancer (PC) pain, up to our knowledge, there is no study compared intraoperative CPN and computed tomography (CT)-guided techniques. Objectives: To compare the effects of intraoperative and CT-guided CPN in unresectable PC on pain intensity and analgesic requirements. Methods: A total of 90 patients were enrolled in this prospective, randomized, open label, controlled, non-inferiority study, 20 patients were excluded or lost to follow up. The patients were randomly allocated to either intraoperative or CT-guided CPN group. A mixture of 20ml ethanol 90%, 100mg lignocaine and 5mg dexamethasone was infused on each side of the aorta in both groups. Visual analogue score (VAS) and oral daily tramadol consumption were recorded at day 7, 14, 30, 60, 120 and 180 days after intervention. Occurrence of any intervention related complications were reported. Results: Median VAS was similar in both intraoperative and CT-guided CPN groups from day 7 up to 180 days after intervention. The median daily analgesic consumption of oral tramadol (mg) was comparable in both intraoperative and CT-guided CPN groups after intervention at day 7 (50 versus 50), day14 (50 versus 50), day 30 (50 versus 50), day 60 (50 versus 50), day 120 (100 versus 75) and day 180 (100 versus 100). The incidence of diarrhea, vomiting, hypotension and back pain was similar in both groups. Conclusion: Intraoperative CPN is non-inferior to CT-guided CPN as both techniques were similarly associated with reduced pain severity and analgesics requirements.(AU)


Subject(s)
Humans , Male , Female , Middle Aged , Celiac Plexus , Pancreatic Neoplasms/complications , Pancreatic Neoplasms/diagnostic imaging , Non-Randomized Controlled Trials as Topic , Tomography, X-Ray Computed , Prospective Studies , Follow-Up Studies , Therapeutics , Treatment Outcome , Anesthesiology , Cardiopulmonary Resuscitation
3.
Article in English, Spanish | MEDLINE | ID: mdl-34565567

ABSTRACT

BACKGROUND: Celiac plexus neurolysis (CPN) has been used to control pancreatic cancer (PC) pain, up to our knowledge, there is no study compared intraoperative CPN and computed tomography (CT)-guided techniques. OBJECTIVES: To compare the effects of intraoperative and CT-guided CPN in unresectable PC on pain intensity and analgesic requirements. METHODS: A total of 90 patients were enrolled in this prospective, randomized, open label, controlled, non-inferiority study, 20 patients were excluded or lost to follow up. The patients were randomly allocated to either intraoperative or CT-guided CPN group. A mixture of 20ml ethanol 90%, 100mg lignocaine and 5mg dexamethasone was infused on each side of the aorta in both groups. Visual analogue score (VAS) and oral daily tramadol consumption were recorded at day 7, 14, 30, 60, 120 and 180 days after intervention. Occurrence of any intervention related complications were reported. RESULTS: Median VAS was similar in both intraoperative and CT-guided CPN groups from day 7 up to 180 days after intervention. The median daily analgesic consumption of oral tramadol (mg) was comparable in both intraoperative and CT-guided CPN groups after intervention at day 7 (50 versus 50), day14 (50 versus 50), day 30 (50 versus 50), day 60 (50 versus 50), day 120 (100 versus 75) and day 180 (100 versus 100). The incidence of diarrhea, vomiting, hypotension and back pain was similar in both groups. CONCLUSION: Intraoperative CPN is non-inferior to CT-guided CPN as both techniques were similarly associated with reduced pain severity and analgesics requirements.

4.
East Mediterr Health J ; 18(8): 827-35, 2012 Aug.
Article in English | MEDLINE | ID: mdl-23057371

ABSTRACT

There is a call for greater preparation for the ethical challenges encountered by physicians in their future professional duties. This study in Egypt aimed to reveal problems and perceived needs for medical ethics education of resident physicians working at University of Alexandria hospitals. In a descriptive, cross-sectional survey, 128 residents answered a self-administered questionnaire. More than half were of the opinion that their medical ethics course was ineffective; 56.3% mentioned poor curricular planning. The majority complained that the subject was not tailored to specialties, the course was too short, there was a shortage of resources to facilitate the educational process and that assessment was done for knowledge but not for skills. Problems related to staffing were low staff:student ratios and staff lack of experience. Trainees, regardless of clinical discipline, felt that there was a great need for improvement to their medicalethics education.


Subject(s)
Ethics, Medical/education , Hospitals, Teaching , Internship and Residency/organization & administration , Cross-Sectional Studies , Egypt , Female , Humans , Male , Medicine , Needs Assessment , Teaching/methods , Time Factors
5.
East Mediterr Health J ; 18(9): 935-45, 2012 Sep.
Article in English | MEDLINE | ID: mdl-23057386

ABSTRACT

This cross-sectional study was conducted to assess the knowledge, perceptions and practices towards medical ethics of physician residents at university hospitals in Alexandria, Egypt. A self-administered structured questionnaire was used for knowledge and perceptions and a checklist for observations of doctor-patient interactions in the outpatient setting. Only 18.0% ofthe 128 participating residents had obtained their knowledge from their medical education and 29.9% were dissatisfied with the roles played by the ethics committee. Most of the residents had satisfactory knowledge and 60.2% had satisfactory perceptions regarding ethical issues. The lowest perception score was in the domain of disclosing medical errors. Only 48.0% of the residents were compliant with the principles of medical ethics in practice and 52.0% of patients were dissatisfied with their treating physicians. The study identified areas of unsatisfactory knowledge and practices towards ethical issues so as to devise means to sensitize residents to these issues and train them appropriately.


Subject(s)
Ethics, Medical/education , Health Knowledge, Attitudes, Practice , Hospitals, University , Internship and Residency/organization & administration , Adult , Attitude of Health Personnel , Confidentiality/ethics , Consumer Behavior , Cross-Sectional Studies , Disclosure/ethics , Egypt , Ethics Committees/organization & administration , Female , Guideline Adherence/statistics & numerical data , Humans , Male , Middle Aged , Patient Rights/ethics , Physician-Patient Relations/ethics , Practice Guidelines as Topic , Socioeconomic Factors , Surveys and Questionnaires
6.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-118337

ABSTRACT

There is a call for greater preparation for the ethical challenges encountered by physicians in their future professional duties. This study in Egypt aimed to reveal problems and perceived needs for medical ethics education of resident physicians working at University of Alexandria hospitals. In a descriptive, cross-sectional survey, 128 residents answered a self-administered questionnaire. More than half were of the opinion that their medical ethics course was ineffective; 56.3% mentioned poor curricular planning. The majority complained that the subject was not tailored to specialties, the course was too short, there was a shortage of resources to facilitate the educational process and that assessment was done for knowledge but not for skills. Problems related to staffing were low staff: student ratios and staff lack of experience. Trainees, regardless of clinical discipline, felt that there was a great need for improvement to their medical ethics education

7.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-118542

ABSTRACT

There is a call for greater preparation for the ethical challenges encountered by physicians in their future professional duties. This study in Egypt aimed to reveal problems and perceived needs for medical ethics education of resident physicians working at University of Alexandria hospitals. In a descriptive, cross-sectional survey, 128 residents answered a self-administered questionnaire. More than half were of the opinion that their medical ethics course was ineffective; 56.3% mentioned poor curricular planning. The majority complained that the subject was not tailored to specialties, the course was too short, there was a shortage of resources to facilitate the educational process and that assessment was done for knowledge but not for skills. Problems related to staffing were low staff:student ratios and staff lack of experience. Trainees, regardless of clinical discipline, felt that there was a great need for improvement to their medical ethics education


Subject(s)
Internship and Residency , Physicians , Hospitals, Teaching , Cross-Sectional Studies , Surveys and Questionnaires , Curriculum , Teaching , Ethics, Medical
8.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-118515

ABSTRACT

This cross-sectional study was conducted to assess the knowledge, perceptions and practices towards medical ethics of physician residents at university hospitals in Alexandria, Egypt. A self-administered structured questionnaire was used for knowledge and perceptions and a checklist for observations of doctor -patient interactions in the outpatient setting. Only 18.0% of the 128 participating residents had obtained their knowledge from their medical education and 29.9% were dissatisfied with the roles played by the ethics committee. Most of the residents had satisfactory knowledge and 60.2% had satisfactory perceptions regarding ethical issues. The lowest perception score was in the domain of disclosing medical errors. Only 48.0% of the residents were compliant with the principles of medical ethics in practice and 52.0% of patients were dissatisfied with their treating physicians. The study identified areas of unsatisfactory knowledge and practices towards ethical issues so as to devise means to sensitize residents to these issues and train them appropriately


Subject(s)
Physicians , Internship and Residency , Health Knowledge, Attitudes, Practice , Cross-Sectional Studies , Hospitals, University , Perception , Surveys and Questionnaires , Ethics, Medical
9.
Bioelectrochemistry ; 80(2): 105-13, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20638913

ABSTRACT

Self-doped poly(aniline)s as electrode coatings to catalyze ascorbate oxidation are revisited in this article. Sulfonated poly(aniline) (SPAN) was deposited on glassy carbon electrodes as a copolymer of aniline and its sulfonated derivative, 2-aminobenzenesulfonic acid (2-ABSA). The resulting deposits are reproducible and show good stability and electroactivity at pH>7, enabling studies at typical physiological pH values. Calibration curves were obtained using a rotating disc electrode at a sampling potential of 0.2V, displaying linear dependence in the region 0-20mM ascorbate. A kinetic model based on the Michaelis-Menten reaction mechanism, previously validated for poly(aniline) composites, was used to analyse the form of the calibration curve leading to values of the effective reaction constants K(ME) and k'(ME). New calibration curves constructed for different sampling potentials were used to elucidate the rate limiting step at saturated kinetics. Rotating disc voltammetry performed at increasing pH (from pH 2 to 9) showed a dramatic decrease in the limiting current, without any evidence for a change in the reaction mechanism.


Subject(s)
Alkanesulfonates/chemistry , Aniline Compounds/chemistry , Ascorbic Acid , Electrodes , Polymers/chemistry , Ascorbic Acid/chemistry , Calibration , Carbon/chemistry , Catalysis , Electrochemistry/methods , Hydrogen-Ion Concentration , Kinetics , Oxidation-Reduction
10.
J Clin Pathol ; 56(2): 107-13, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12560388

ABSTRACT

AIMS: To investigate the prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor Flt-1 in nephroblastoma and whether tumour microvessel density (MVD) immunoreactivity, determined by the CD31 antigen, is related to the expression of VEGF and Flt-1. METHODS: The expression of VEGF and Flt-1 and MVD were investigated by means of immunohistochemical analysis in 62 Wilms's tumours. Patients were treated preoperatively with chemotherapy and had a mean follow up of 5.7 years. RESULTS: In general, VEGF and Flt-1 were expressed in normal kidney parenchyma and to a variable extent in the three main components of Wilms's tumour, namely: the blastemal, epithelial, and stromal cells. In tumour tissue, 52% and 47% of blastemal cells were positive for VEGF and Flt-1, respectively. A non-significant correlation was found between the expression of VEGF and Flt-1 in blastemal and epithelial cells and the clinicopathological stage. MVD was significantly higher in VEGF and Flt-1 positive tumours than in VEGF and Flt-1 negative tumours. Univariate analysis showed that the expression of VEGF and Flt-1 in blastemal cells was indicative of clinical progression and tumour specific survival. In addition, MVD expression was indicative of clinical progression. Epithelial staining was of no prognostic value. In a multivariate analysis, VEGF protein expression by blastemal cells was an independent prognostic marker for clinical progression. CONCLUSIONS: These results indicate that VEGF and Flt-1 protein expression are closely related to MVD and seem to be an important predictor for poor prognosis in treated patients with Wilms's tumour. Therefore, the expression of these molecules in primary Wilms's tumour may be useful in identifying those patients at high risk of tumour recurrence and in guiding antiangiogenic treatment.


Subject(s)
Kidney Neoplasms/metabolism , Neoplasm Proteins/metabolism , Neovascularization, Pathologic/metabolism , Vascular Endothelial Growth Factor Receptor-1/metabolism , Wilms Tumor/metabolism , Analysis of Variance , Child , Child, Preschool , Disease Progression , Female , Follow-Up Studies , Humans , Immunoenzyme Techniques , Kidney Neoplasms/blood supply , Kidney Neoplasms/therapy , Male , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Prognosis , Survival Rate , Wilms Tumor/blood supply , Wilms Tumor/therapy
11.
Cancer ; 92(12): 3120-9, 2001 Dec 15.
Article in English | MEDLINE | ID: mdl-11753991

ABSTRACT

BACKGROUND: Wilms tumor is one of the most common solid tumors in children. A transforming growth factor-alpha (TGF-alpha)/epidermal growth factor receptor (EGF-R) autocrine loop plays an important role in tumor growth. Abnormal expression of TGF-alpha, EGF-R and c-erb B-2 has been demonstrated in several human malignancies. METHODS: The immunohistochemical expression of TGF-alpha, EGF-R, and c-erb B-2 was studied in paraffin material of 62 clinical Wilms tumors. Patients had a mean follow-up of 5.7 years. RESULTS: Generally, TGF-alpha, EGF-R, and c-erb B-2 were expressed in tissue of the normal kidney and at variable levels in the three cell types of Wilms tumor, i.e., blastemal, epithelial, and stromal cells. Immunoreactive blastema cells were found in 48%, 44%, and 34% of tumors for TGF-alpha, EGF-R, and c-erb B-2, respectively. It was found that TGF-alpha, EGF-R, and c-erb B-2 blastemal and epithelial expression gradually increased from T1 to T3. The blastemal expression of TGF-alpha was statistically significantly correlated with clinicopathologic stages. Both univariate and multivariate analysis showed that blastemal TGF-alpha expression was indicative for clinical progression, but neither blastemal TGF-alpha, nor EGF-R or c-erb B-2 expression correlated with patients survival. Epithelial staining was of no prognostic value. The simultaneous expression of TGF-alpha/EGF-R was indicative for clinical progression at univariate level. CONCLUSIONS: Increased expression of TGF-alpha in the blastemal part of Wilms tumor correlated with tumor classification and clinical progression. These findings suggest that significant expression of TGF-alpha and EGF-R may play a role in promoting transformation and/or proliferation of Wilms tumor, perhaps by an autocrine mechanism. Therefore, their expression may be of value in identifying patients at high risk of tumor recurrence.


Subject(s)
ErbB Receptors/biosynthesis , Gene Expression Regulation, Neoplastic , Kidney Neoplasms/pathology , Neoplasm Recurrence, Local , Receptor, ErbB-2/biosynthesis , Transforming Growth Factor beta/biosynthesis , Wilms Tumor/pathology , Biomarkers, Tumor/analysis , Child , Child, Preschool , Disease Progression , ErbB Receptors/analysis , Female , Humans , Immunohistochemistry , Kidney Neoplasms/genetics , Male , Prognosis , Receptor, ErbB-2/analysis , Risk Factors , Transforming Growth Factor beta/analysis , Wilms Tumor/genetics
12.
Phys Rev Lett ; 87(17): 176801, 2001 Oct 22.
Article in English | MEDLINE | ID: mdl-11690291

ABSTRACT

We investigate the properties of gold surfaces patterned using a nanoscale "lost wax" technique by electrochemical deposition through a self-assembled latex template. Near-spherical gold nanocavities within the resulting porous films support localized surface plasmons which couple strongly to incident light, appearing as sharp spectral features in reflectivity measurements. The energy of the resonances is easily tunable from ultraviolet to near infrared by controlling the diameter and height of the nanocavities. The energies of these features agree well with the Mie resonances of a perfect spherical void.

13.
Br J Cancer ; 85(10): 1557-63, 2001 Nov 16.
Article in English | MEDLINE | ID: mdl-11720445

ABSTRACT

Apoptotic cell death represents an important mechanism for the precise regulation of cell numbers in normal tissues. Various apoptosis-associated regulatory proteins, such as Bcl-2, Bax and Bcl-X, may contribute to the rate of apoptosis in neoplasia. The present study was performed to evaluate the prognostic value of these molecules in a group of 61 Wilms' tumours of chemotherapeutically pre-treated patients using an immunohistochemical approach. Generally, Bcl-2, Bax and for Bcl-X(S/L) were expressed in the blastemal and epithelial components of Wilms' tumour. Immunoreactive blastema cells were found in 53%, 41% and 38% of tumours for Bcl-2, Bax and for Bcl-X(S/L), respectively. An increased expression of Bcl-2 was observed in the blastemal component of increasing pathological stages. In contrast, a gradual decline of Bax expression was observed in the blastemal component of tumours with increasing pathological stages. Also blastemal Bcl-X(S/L) expression decreased with stage. Univariate analysis showed that blastemal Bcl-2 expression and the Bcl-2/Bax ratio were indicative for clinical progression, whereas epithelial staining was of no prognostic value. Multivariate analysis showed that blastemal Bcl-2 expression is an independent prognostic marker for clinical progression besides stage. These findings demonstrate that alterations of the Bcl-2/Bax balance may influence the clinical outcome of Wilms' tumour patients by deregulation of programmed cell death.


Subject(s)
Apoptosis , Biomarkers, Tumor/metabolism , Kidney Neoplasms/diagnosis , Proto-Oncogene Proteins c-bcl-2/metabolism , Proto-Oncogene Proteins/metabolism , Wilms Tumor/diagnosis , Child, Preschool , Disease Progression , Female , Humans , Immunohistochemistry , Kidney/metabolism , Kidney Neoplasms/metabolism , Kidney Neoplasms/pathology , Male , Prognosis , Proto-Oncogene Proteins/immunology , Proto-Oncogene Proteins c-bcl-2/immunology , Treatment Outcome , Wilms Tumor/metabolism , Wilms Tumor/pathology , bcl-2-Associated X Protein , bcl-X Protein
14.
Clin Cancer Res ; 6(11): 4265-71, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11106242

ABSTRACT

Wilms' tumor is one of the most common solid tumors of children. The protein product of the tumor-suppressor gene, Wilms' tumor 1 (WT-1), binds to the same DNA sequences as the protein product of the early growth response 1 (EGR-1) gene. There is experimental evidence that EGR-1 is involved in controlling cell growth. The expression of both genes in Wilms' tumor was studied by others, mainly at the mRNA level. The present study evaluates the prognostic value of WT-1 and EGR-1 in 61 Wilms' tumors of chemotherapeutically treated patients at the protein level, using an immunohistochemical approach. WT-1 was expressed in normal kidney tissues and in the blastemal and epithelial component of Wilms' tumor, whereas stromal tissue was negative. EGR-1 was expressed in normal kidney tissues and in the three main cell types of Wilms' tumor. In 59 and 56% of Wilms' tumor, the blastemal cells stained for WT-1 and EGR-1, respectively. The blastemal expression of WT-1 and EGR-1 and the epithelial expression of WT-1 were statistically significantly correlated with clinical stage. WT-1 immunoreactivity correlated with EGR-1 expression. Univariate analysis showed that blastemal WT-1 and EGR-1 expression were indicative for clinical progression and tumor-specific survival, whereas epithelial staining was of no prognostic value. Multivariate analysis showed that blastemal WT-1 expression is an independent prognostic marker for clinical progression other than stage. We conclude that a relationship exists between WT-1 and EGR-1 expression in clinical nephroblastomas. Blastemal WT-1 and EGR-1 expression is related to prognosis.


Subject(s)
DNA-Binding Proteins/analysis , Immediate-Early Proteins , Kidney Neoplasms/chemistry , Transcription Factors/analysis , Wilms Tumor/chemistry , DNA-Binding Proteins/genetics , Early Growth Response Protein 1 , Humans , Immunoblotting , Immunohistochemistry , Kidney Neoplasms/mortality , Kidney Neoplasms/pathology , Multivariate Analysis , Prognosis , Transcription Factors/genetics , WT1 Proteins , Wilms Tumor/mortality , Wilms Tumor/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...